Copyright Reports & Markets. All rights reserved.

Global Glycosylated Biosimilars Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Glycosylated Biosimilars Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 mAb
    • 1.2.3 EPO
  • 1.3 Market by Application
    • 1.3.1 Global Glycosylated Biosimilars Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Oncology
    • 1.3.3 Chronic Diseases
    • 1.3.4 Autoimmune Diseases
    • 1.3.5 Blood Disorders
    • 1.3.6 Growth Hormone Deficiency
    • 1.3.7 Infectious Diseases
    • 1.3.8 Other Diseases
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Glycosylated Biosimilars Market Perspective (2016-2027)
  • 2.2 Glycosylated Biosimilars Growth Trends by Regions
    • 2.2.1 Glycosylated Biosimilars Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Glycosylated Biosimilars Historic Market Share by Regions (2016-2021)
    • 2.2.3 Glycosylated Biosimilars Forecasted Market Size by Regions (2022-2027)
  • 2.3 Glycosylated Biosimilars Industry Dynamic
    • 2.3.1 Glycosylated Biosimilars Market Trends
    • 2.3.2 Glycosylated Biosimilars Market Drivers
    • 2.3.3 Glycosylated Biosimilars Market Challenges
    • 2.3.4 Glycosylated Biosimilars Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Glycosylated Biosimilars Players by Revenue
    • 3.1.1 Global Top Glycosylated Biosimilars Players by Revenue (2016-2021)
    • 3.1.2 Global Glycosylated Biosimilars Revenue Market Share by Players (2016-2021)
  • 3.2 Global Glycosylated Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Glycosylated Biosimilars Revenue
  • 3.4 Global Glycosylated Biosimilars Market Concentration Ratio
    • 3.4.1 Global Glycosylated Biosimilars Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Glycosylated Biosimilars Revenue in 2020
  • 3.5 Glycosylated Biosimilars Key Players Head office and Area Served
  • 3.6 Key Players Glycosylated Biosimilars Product Solution and Service
  • 3.7 Date of Enter into Glycosylated Biosimilars Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Glycosylated Biosimilars Breakdown Data by Type

  • 4.1 Global Glycosylated Biosimilars Historic Market Size by Type (2016-2021)
  • 4.2 Global Glycosylated Biosimilars Forecasted Market Size by Type (2022-2027)

5 Glycosylated Biosimilars Breakdown Data by Application

  • 5.1 Global Glycosylated Biosimilars Historic Market Size by Application (2016-2021)
  • 5.2 Global Glycosylated Biosimilars Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Glycosylated Biosimilars Market Size (2016-2027)
  • 6.2 North America Glycosylated Biosimilars Market Size by Type
    • 6.2.1 North America Glycosylated Biosimilars Market Size by Type (2016-2021)
    • 6.2.2 North America Glycosylated Biosimilars Market Size by Type (2022-2027)
    • 6.2.3 North America Glycosylated Biosimilars Market Size by Type (2016-2027)
  • 6.3 North America Glycosylated Biosimilars Market Size by Application
    • 6.3.1 North America Glycosylated Biosimilars Market Size by Application (2016-2021)
    • 6.3.2 North America Glycosylated Biosimilars Market Size by Application (2022-2027)
    • 6.3.3 North America Glycosylated Biosimilars Market Size by Application (2016-2027)
  • 6.4 North America Glycosylated Biosimilars Market Size by Country
    • 6.4.1 North America Glycosylated Biosimilars Market Size by Country (2016-2021)
    • 6.4.2 North America Glycosylated Biosimilars Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Glycosylated Biosimilars Market Size (2016-2027)
  • 7.2 Europe Glycosylated Biosimilars Market Size by Type
    • 7.2.1 Europe Glycosylated Biosimilars Market Size by Type (2016-2021)
    • 7.2.2 Europe Glycosylated Biosimilars Market Size by Type (2022-2027)
    • 7.2.3 Europe Glycosylated Biosimilars Market Size by Type (2016-2027)
  • 7.3 Europe Glycosylated Biosimilars Market Size by Application
    • 7.3.1 Europe Glycosylated Biosimilars Market Size by Application (2016-2021)
    • 7.3.2 Europe Glycosylated Biosimilars Market Size by Application (2022-2027)
    • 7.3.3 Europe Glycosylated Biosimilars Market Size by Application (2016-2027)
  • 7.4 Europe Glycosylated Biosimilars Market Size by Country
    • 7.4.1 Europe Glycosylated Biosimilars Market Size by Country (2016-2021)
    • 7.4.2 Europe Glycosylated Biosimilars Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Glycosylated Biosimilars Market Size (2016-2027)
  • 8.2 Asia-Pacific Glycosylated Biosimilars Market Size by Type
    • 8.2.1 Asia-Pacific Glycosylated Biosimilars Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Glycosylated Biosimilars Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Glycosylated Biosimilars Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Glycosylated Biosimilars Market Size by Application
    • 8.3.1 Asia-Pacific Glycosylated Biosimilars Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Glycosylated Biosimilars Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Glycosylated Biosimilars Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Glycosylated Biosimilars Market Size by Region
    • 8.4.1 Asia-Pacific Glycosylated Biosimilars Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Glycosylated Biosimilars Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Glycosylated Biosimilars Market Size (2016-2027)
  • 9.2 Latin America Glycosylated Biosimilars Market Size by Type
    • 9.2.1 Latin America Glycosylated Biosimilars Market Size by Type (2016-2021)
    • 9.2.2 Latin America Glycosylated Biosimilars Market Size by Type (2022-2027)
    • 9.2.3 Latin America Glycosylated Biosimilars Market Size by Type (2016-2027)
  • 9.3 Latin America Glycosylated Biosimilars Market Size by Application
    • 9.3.1 Latin America Glycosylated Biosimilars Market Size by Application (2016-2021)
    • 9.3.2 Latin America Glycosylated Biosimilars Market Size by Application (2022-2027)
    • 9.3.3 Latin America Glycosylated Biosimilars Market Size by Application (2016-2027)
  • 9.4 Latin America Glycosylated Biosimilars Market Size by Country
    • 9.4.1 Latin America Glycosylated Biosimilars Market Size by Country (2016-2021)
    • 9.4.2 Latin America Glycosylated Biosimilars Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Glycosylated Biosimilars Market Size (2016-2027)
  • 10.2 Middle East & Africa Glycosylated Biosimilars Market Size by Type
    • 10.2.1 Middle East & Africa Glycosylated Biosimilars Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Glycosylated Biosimilars Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Glycosylated Biosimilars Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Glycosylated Biosimilars Market Size by Application
    • 10.3.1 Middle East & Africa Glycosylated Biosimilars Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Glycosylated Biosimilars Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Glycosylated Biosimilars Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Glycosylated Biosimilars Market Size by Country
    • 10.4.1 Middle East & Africa Glycosylated Biosimilars Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Glycosylated Biosimilars Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sandoz
    • 11.1.1 Sandoz Company Details
    • 11.1.2 Sandoz Business Overview
    • 11.1.3 Sandoz Glycosylated Biosimilars Introduction
    • 11.1.4 Sandoz Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.1.5 Sandoz Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Glycosylated Biosimilars Introduction
    • 11.2.4 Pfizer Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.2.5 Pfizer Recent Development
  • 11.3 Teva Pahrmaceutical
    • 11.3.1 Teva Pahrmaceutical Company Details
    • 11.3.2 Teva Pahrmaceutical Business Overview
    • 11.3.3 Teva Pahrmaceutical Glycosylated Biosimilars Introduction
    • 11.3.4 Teva Pahrmaceutical Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.3.5 Teva Pahrmaceutical Recent Development
  • 11.4 Celltrion
    • 11.4.1 Celltrion Company Details
    • 11.4.2 Celltrion Business Overview
    • 11.4.3 Celltrion Glycosylated Biosimilars Introduction
    • 11.4.4 Celltrion Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.4.5 Celltrion Recent Development
  • 11.5 Biocon
    • 11.5.1 Biocon Company Details
    • 11.5.2 Biocon Business Overview
    • 11.5.3 Biocon Glycosylated Biosimilars Introduction
    • 11.5.4 Biocon Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.5.5 Biocon Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Glycosylated Biosimilars Introduction
    • 11.6.4 Amgen Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.6.5 Amgen Recent Development
  • 11.7 Samsung Biologics
    • 11.7.1 Samsung Biologics Company Details
    • 11.7.2 Samsung Biologics Business Overview
    • 11.7.3 Samsung Biologics Glycosylated Biosimilars Introduction
    • 11.7.4 Samsung Biologics Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.7.5 Samsung Biologics Recent Development
  • 11.8 Mylan
    • 11.8.1 Mylan Company Details
    • 11.8.2 Mylan Business Overview
    • 11.8.3 Mylan Glycosylated Biosimilars Introduction
    • 11.8.4 Mylan Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.8.5 Mylan Recent Development
  • 11.9 Dr. Reddy's Laboratories
    • 11.9.1 Dr. Reddy's Laboratories Company Details
    • 11.9.2 Dr. Reddy's Laboratories Business Overview
    • 11.9.3 Dr. Reddy's Laboratories Glycosylated Biosimilars Introduction
    • 11.9.4 Dr. Reddy's Laboratories Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.9.5 Dr. Reddy's Laboratories Recent Development
  • 11.10 Stada Arzneimittel AG
    • 11.10.1 Stada Arzneimittel AG Company Details
    • 11.10.2 Stada Arzneimittel AG Business Overview
    • 11.10.3 Stada Arzneimittel AG Glycosylated Biosimilars Introduction
    • 11.10.4 Stada Arzneimittel AG Revenue in Glycosylated Biosimilars Business (2016-2021)
    • 11.10.5 Stada Arzneimittel AG Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Glycosylated Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glycosylated Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    mAb
    EPO

    Segment by Application
    Oncology
    Chronic Diseases
    Autoimmune Diseases
    Blood Disorders
    Growth Hormone Deficiency
    Infectious Diseases
    Other Diseases

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Sandoz
    Pfizer
    Teva Pahrmaceutical
    Celltrion
    Biocon
    Amgen
    Samsung Biologics
    Mylan
    Dr. Reddy's Laboratories
    Celltrion

    Buy now